Related by context. All words. (Click for frequent words.) 70 bezafibrate 69 endometrial hyperplasia 69 probiotic supplementation 69 riociguat 69 colorectal adenoma 69 alkylating agent 68 liver metastasis 68 H pylori 68 antitumor effect 68 locoregional recurrence 68 β blockers 68 bovine thrombin 68 antiangiogenic 68 pentoxifylline 67 idarubicin 67 thromboembolic disease 67 micafungin 67 antiresorptive 67 relapsed MM 67 antiarrhythmic 67 AGILECT R 67 LHRH agonists 67 cediranib 67 GnRH agonists 67 pegylated liposomal doxorubicin 67 trastuzumab Herceptin ® 67 idraparinux 67 paroxysmal AF 67 lenalidomide dexamethasone 67 allogeneic HSCT 67 mycophenolate mofetil 67 caspofungin 66 antioxidant supplementation 66 pharmacokinetic interactions 66 complete cytogenetic response 66 TNF antagonist 66 interferon ribavirin 66 CYP #A# 66 EXJADE 66 budesonide foam 66 ganciclovir 66 deferiprone 66 thalidomide Thalomid 66 olmesartan 66 corticosteroid therapy 66 endometrial carcinoma 66 diabetic kidney 66 fibrate drugs 66 pomalidomide 66 recurrent venous thromboembolism 66 pancreatic insufficiency 66 zoledronate 66 androgen suppression 66 hydroxychloroquine 66 FUSILEV enhances 66 renal toxicity 66 potassium sparing diuretics 66 TMP SMX 66 griseofulvin 66 tolvaptan 66 corticosteroid dexamethasone 66 posaconazole 66 venous thromboembolic events 66 intravesical therapy 66 folinic acid 66 trimethoprim sulfamethoxazole 66 Tavocept 65 EGFRIs 65 gemifloxacin 65 systemic corticosteroid 65 DHEA supplementation 65 androgen ablation 65 ximelagatran 65 antiandrogens 65 cytoreduction 65 salmeterol fluticasone 65 intravenous bisphosphonates 65 postoperative AF 65 Thal Dex 65 microbiological eradication 65 nicotinic acid 65 antihypertensive therapy 65 radiochemotherapy 65 paricalcitol 65 CP CPPS 65 hepatotoxic 65 ATACAND 65 amifostine 65 plasminogen activators 65 H2 blocker 65 dexrazoxane 65 invasive candidiasis 65 IV bisphosphonates 65 hematologic parameters 65 DFMO 65 Dasatinib 65 Adjuvant chemotherapy 65 voriconazole 65 antiarrhythmic drug 65 hepatic cirrhosis 65 rhTSH 65 acid secretion 65 hepatorenal syndrome 65 cytotoxic effects 65 prednisone prednisolone 65 torsade de pointes 65 NATRECOR ® 65 nonalcoholic steatohepatitis NASH 65 gastric adenocarcinoma 65 gadobutrol 65 skeletal metastases 65 antiandrogen 65 glycated hemoglobin levels 65 MAGE A3 ASCI 65 selenium supplementation 65 hypertonic saline 65 goserelin 65 lomitapide 65 flutamide 65 imipenem 65 carcinoids 65 regorafenib 65 acetylcysteine 65 itraconazole 65 CYT# potent vascular disrupting 64 anthracycline taxane 64 polyp recurrence 64 vidofludimus 64 IFN beta 64 vasodilatation 64 irinotecan chemotherapy 64 postoperative morbidity 64 chemoradiotherapy 64 indinavir 64 haematologic 64 conjugated estrogen 64 beta carotene supplementation 64 Velcade bortezomib 64 candidemia 64 hepatic enzymes 64 Thalomid ® 64 trans retinoic acid 64 statins cholesterol lowering 64 HMG CoA reductase inhibitors 64 secondary amenorrhea 64 cranial irradiation 64 invasive aspergillosis 64 bexarotene 64 sulphonylureas 64 Chronic pancreatitis 64 intermittent hypoxia 64 cilostazol 64 colorectal tumors 64 adriamycin 64 titrated glipizide 64 oral mTOR inhibitor 64 clomipramine 64 hematological toxicity 64 pyrimethamine 64 chemopreventive agent 64 AEG# 64 erlotinib Tarceva 64 CIMZIA ™ 64 folic acid vitamin B# 64 nephrotoxicity 64 intensive lipid lowering 64 testosterone supplementation 64 hypocalcaemia 64 hyperphenylalaninemia HPA due 64 thrombotic complications 64 antiangiogenic therapy 64 recurrent genital herpes 64 immunosuppressive medication 64 serum urate levels 64 thromboembolic 64 pyrazinamide 64 antiemetics 64 recurrent glioblastoma multiforme 64 cytoreductive surgery 64 colorectal liver metastases 64 mRCC 64 QTc prolongation 64 radioiodine therapy 64 curative resection 64 PASI scores 64 relapsed ovarian cancer 64 estramustine 64 MGd 64 temsirolimus 64 Cytoxan 64 metastatic malignant 64 forodesine 64 Natalizumab 64 secondary hyperparathyroidism 64 tamoxifen Nolvadex ® 64 multimodality therapy 64 mapatumumab 64 antiepileptic drugs AEDs 64 aldosterone antagonist 64 sitaxsentan 64 primidone 64 elevated serum creatinine 64 oral prodrug 64 benign prostatic hypertrophy BPH 64 intracranial hemorrhage ICH 64 hepatotoxicity 64 hypophosphatemia 64 rFVIIa 64 antibiotic rifaximin 64 Topical corticosteroids 64 hypoperfusion 64 nonmelanoma skin cancers 64 autoimmune reactions 64 anticoagulant warfarin 64 L lysine 64 insulin sensitizing 64 oxaliplatin Eloxatin 64 atopic disease 64 cisplatin resistant 64 postoperative atrial fibrillation 64 diabetic gastroparesis 64 tylosin 64 primary hyperparathyroidism 64 XZK 64 intravenous cyclophosphamide 64 recurrent VTE 64 abacavir lamivudine 64 amoxicillin clavulanate 64 dexpramipexole 64 anti androgen 64 plasma kallikrein inhibitor 64 gemcitabine Gemzar 64 kidney urologic 64 sotalol 64 pharmacologically active isomer 64 oral rivaroxaban 64 standard chemotherapy regimen 64 cardiotoxic 64 fibrin deposition 64 NNRTI resistance 64 serum phosphate 64 thiazide diuretic 64 bicalutamide 64 STRIDE PD 64 noscapine 64 CDI recurrence 64 velafermin 64 ethambutol 64 antiangiogenesis 64 deferoxamine 64 bacterial overgrowth 64 antiarrhythmic drugs 64 genotypic resistance 63 antiplatelet therapies 63 vitamin B# folic acid 63 EUS FNA 63 tumor necrosis 63 xanthine oxidase inhibitor 63 lowering blood glucose 63 aminoglycoside 63 KRAS mutations occur 63 LNG IUS 63 breast endometrial 63 lipid lowering therapies 63 nucleoside analogs 63 FOLFOX4 63 SSc 63 chemoradiation therapy 63 mTOR inhibition 63 combination antiretroviral therapy 63 Helicobacter pylori eradication 63 phosphate binders 63 sargramostim 63 cerebral vasospasm 63 pCR 63 genital herpes infections 63 sitosterol 63 KRAS mutant tumors 63 Doxil ® 63 alkalosis 63 inducible nitric oxide synthase 63 leukotriene receptor antagonist 63 peritoneal carcinomatosis 63 erythropoietic 63 Irinotecan 63 CIMZIA TM 63 androgen deprivation 63 superficial bladder cancer 63 C1 INH 63 HBeAg seroconversion 63 PTHrP 63 MS relapses 63 bacteriuria 63 Degarelix 63 pulmonary toxicity 63 serum biomarkers 63 nondiabetic patients 63 docetaxel chemotherapy 63 histologic subtype 63 myocardial reperfusion 63 iniparib 63 Azathioprine 63 EFAPROXYN 63 steroid dexamethasone 63 Candida infections 63 Hypotension 63 Mg Uk 63 immunosuppressive regimens 63 aspirin clopidogrel 63 receptor inhibitor 63 pediatric malignancies 63 Navelbine ® 63 Cyclosporine 63 dapsone 63 neutropenic 63 immunosuppressive therapies 63 Navelbine 63 MYLOTARG 63 ibandronate 63 conventional DMARDs 63 aminotransferases 63 LHRH analogues 63 edifoligide 63 mixed hyperlipidemia 63 oxcarbazepine 63 immunosuppressive agents 63 alpha blocker 63 pyridostigmine 63 interleukin IL -# 63 MMX mesalamine 63 lenalidomide Revlimid R 63 aliskiren amlodipine 63 neutropenic patients 63 overt nephropathy 63 calcineurin inhibitors 63 CR nPR 63 intensive statin therapy 63 azacytidine 63 Kepivance 63 therapeutic regimens 63 mTOR inhibitors 63 imatinib Gleevec 63 lung metastasis 63 C1 INH deficiency 63 Histalean TM 63 NIASPAN 63 hypercholesterolaemia 63 pamidronate 63 prostate cancer CaP 63 nutlin 3a 63 Granulocyte Colony Stimulating Factor 63 myopathy rhabdomyolysis 63 adjuvant radiotherapy 63 endoxifen 63 perioperative morbidity 63 terlipressin 63 CTAP# Capsules 63 forskolin 63 rabeprazole 63 N telopeptide 63 bleomycin 63 vulvovaginal candidiasis 63 salmeterol HFA MDI 63 antiangiogenic agents 63 serum cortisol 63 E. faecalis 63 ABVD 63 balsalazide 63 impair fertility 63 antiangiogenic agent 63 platelet activation 63 nitrofurantoin 63 K ras mutations 63 antiplatelet agent 63 PEGINTRON TM 63 Oral corticosteroids 63 cisplatin gemcitabine 63 rHuEPO 63 HER2 expression 63 fibrinolytic 63 antidepressants SSRIs 63 azelaic acid 63 antiplatelet medication 63 gastroesophageal junction 63 FOLFOX6 63 amphotericin B 63 antidiabetic 63 hyperphosphatemia 63 postoperative chemotherapy 63 fibrotic disease 63 nocturnal hypoglycaemia 63 metabolic disturbances 63 octreotide LAR 63 ritonavir boosted 63 #F FDG PET 63 Pemetrexed 63 ziconotide 63 #mg/day [002] 63 antirheumatic 63 TNF blocker therapy 63 ADPKD 63 GIST tumors 63 INTEGRILIN 63 sulindac 63 invasive fungal infection 63 hypoglycemic episodes 63 acid suppressing 63 azole 62 antihypertensive medication 62 basiliximab 62 N acetylcysteine 62 tranylcypromine 62 Dacogen decitabine 62 glomerular filtration 62 APTIVUS 62 iloprost 62 acitretin 62 pouchitis 62 hepatic fibrosis 62 eplerenone 62 immune dysregulation 62 metformin sulfonylurea 62 suppressive therapy 62 reinfarction 62 Taxol paclitaxel 62 candesartan cilexetil 62 PROCHYMAL 62 lapatinib Tykerb 62 interferon alfa 2b 62 TNF alpha inhibitor 62 mutated KRAS 62 rosuvastatin #mg 62 cisplatin chemotherapy 62 eprotirome 62 PROSTVAC VF 62 direct thrombin inhibitors 62 lipid lowering agents 62 tigecycline 62 preoperative chemotherapy 62 inotropic 62 fulvestrant 62 HCV replicon 62 BYSTOLIC 62 coadministration 62 evaluating tivozanib 62 atrophic gastritis 62 Pegylated Interferon 62 cardiovascular calcification 62 homocysteine concentrations 62 leukaemic stem cells 62 EDARBI 62 chronic thromboembolic pulmonary 62 Camptosar ® 62 antifibrinolytic 62 sorafenib tablets 62 Nexavar sorafenib 62 perioperatively 62 neutrophil counts 62 receptor tyrosine kinase inhibitor 62 mycophenolate mofetil MMF 62 AGHD 62 TNF α 62 irbesartan 62 natriuretic peptides 62 autoantibody levels 62 parasitemia 62 androgen suppression therapy 62 anticlotting 62 antigen PSA levels 62 taxane chemotherapy 62 gp# vaccine 62 Decitabine 62 intestinal polyps 62 adrenocorticotropic hormone ACTH 62 HbF 62 concurrent chemoradiation 62 tHcy 62 serum phosphate levels 62 rituximab Rituxan 62 vasodilators 62 d4T stavudine Zerit 62 aromatase inhibitor therapy 62 intra arterial chemotherapy 62 cardiac toxicity 62 eculizumab therapy 62 cardiovascular morbidity 62 virological response 62 lipid lowering therapy 62 dysglycemia 62 tipifarnib 62 elotuzumab 62 chemoprotective 62 serum calcium levels 62 hepatic metabolism 62 hemorrhagic complications 62 Erythropoietic therapies may 62 sustained virological response 62 mitochondrial toxicity 62 elacytarabine 62 hepatic toxicity 62 metastatic GIST 62 premalignant lesions 62 unresectable tumors 62 FOSRENOL ® 62 cabazitaxel 62 advanced adenomas 62 flecainide 62 post surgical adhesions 62 lobular carcinoma 62 locoregional 62 abacavir Ziagen 62 imatinib therapy 62 calcineurin inhibitor 62 radiosensitivity 62 infliximab Remicade 62 OHR/AVR# 62 renal excretion 62 urothelial cancer 62 blood thinner Warfarin 62 AZT zidovudine Retrovir 62 visilizumab 62 thromboembolic complications 62 Vfend 62 EGFR tyrosine kinase inhibitors 62 liposomal amphotericin B 62 N acetyl cysteine 62 Crestor rosuvastatin 62 oleanolic acid 62 Pseudomonas aeruginosa infections 62 advanced adenoma 62 thromboembolic events 62 Triapine R 62 Helicobacter pylori H. pylori 62 hematopoietic cancers 62 intra abdominal abscess 62 sevelamer 62 ZOLINZA 62 mCRC patients 62 epithelial tumors 62 Serious adverse reactions 62 oral diclofenac 62 postoperative radiotherapy 62 beta lactam antibiotic 62 tumor recurrence 62 hypoxemia 62 Lactobacillus GG 62 cardioprotection 62 sustained virologic response 62 ALV# 62 Hepatocellular Carcinoma HCC 62 Rezular 62 nonalcoholic steatohepatitis 62 cinacalcet 62 antithrombotic therapy 62 reperfusion injury 62 gefitinib Iressa 62 serum uric acid 62 malabsorptive 62 sulphonylurea 62 CYPHER Stent 62 SPRYCEL ® 62 Zollinger Ellison Syndrome 62 bronchoalveolar 62 invasive ductal 62 bilateral oophorectomy 62 relapsed AML 62 Hydroxyurea 62 dose dependently 62 galiximab 62 verapamil 62 Febrile neutropenia 62 Dose escalation 62 H2 antagonists 62 intestinal metaplasia 62 relapsing remitting MS RRMS 62 CANCIDAS 62 isoenzyme 62 RAS blockers 62 antiplatelet therapy 62 benfotiamine 62 metastatic lesions 62 IOP lowering 62 CsA 62 adrenal suppression 62 Calcium intake 62 Ceplene/IL-2 62 postoperative ileus 62 maximal doses 62 SCCHN 62 serum calcium 62 renal biopsy 62 pelvic lymphadenectomy 62 ventricular remodeling 62 mutated K ras 62 alefacept 62 Gleevec imatinib 62 systemic antifungal 62 recombinant erythropoietin 62 oral hypoglycemic agents 62 TYSABRI natalizumab 62 eosinophil count 62 hyperparathyroidism 62 hepatocellular carcinomas 62 F FDG PET 62 macrovascular events 62 thiazides 62 clodronate 62 metastatic lung cancer 62 poststroke depression 62 interferon beta therapy 62 taxotere 62 SSRI SNRI 62 acute GvHD 62 Aspergillus species 62 cefazolin 62 hyperoxaluria 62 hypercalciuria 62 fumagillin nanoparticles 62 oral clodronate 62 delayed CINV 62 T2DM 62 glycosylated hemoglobin HbA1c 62 platelet inhibitor 62 COPD exacerbations 62 corticosteroid dose 62 Noxafil 62 ReA 62 ertapenem 62 photodamaged skin 62 oral anticoagulation 62 ALA PDT 62 YONDELIS 62 Cancidas 62 cardiac glycosides 62 external beam radiotherapy 62 airway hyper responsiveness 62 KRAS status 62 Losartan 62 thiazide diuretics 62 endocrine therapies 62 metastatic lymph nodes 62 plasma pharmacokinetics 62 GnRH agonist 62 elevated triglyceride levels 62 immunomodulatory therapy 62 thromboprophylaxis 62 H2 receptor antagonists 62 serum BDNF 62 KETEK 62 lichen planus 62 CBLC# 62 tolterodine ER 62 aprepitant 62 MULTAQ 62 Zavesca ® 62 adjunctive placebo 62 thiopurine 62 trials RCTs 62 papillary renal cell carcinoma 62 NRTI 62 amikacin 62 conventional angiography 62 biliary obstruction 62 vWF 62 EGFR TKI 62 treprostinil 62 nonischemic 62 oral antidiabetic medication 62 antireflux surgery 62 ticlopidine 62 RSD# oral 62 lumiliximab 62 intact parathyroid hormone 62 TNFa 62 prucalopride 62 oral antidiabetes 61 RISPERDAL ® 61 macrolide antibiotics 61 pulmonary metastases 61 thrombocytopenic 61 5FU 61 residual confounding 61 dexamethasone Decadron 61 CHOP chemotherapy 61 selective modulator 61 DMARDS 61 somatostatin analogues 61 MGUS 61 colorectal carcinoma 61 Desmopressin 61 liposomal doxorubicin 61 morphometric vertebral fractures 61 HAART regimens 61 CETP inhibition 61 losartan Cozaar 61 metaplasia 61 anagrelide 61 TORISEL 61 symptomatic VTE 61 urolithiasis 61 Helicobacter pylori infection 61 fluoroquinolone resistance 61 Factor Xa inhibitors 61 uric acid lowering 61 cefuroxime 61 alpha interferon 61 cytopenias 61 indolent NHL 61 cilengitide 61 SERMs 61 hypokalemia 61 HIF PHI 61 mitomycin C 61 anakinra 61 HGPIN 61 Th2 cytokines 61 nicardipine 61 Fludara 61 MyVax R 61 treat dysmenorrhea 61 imatinib resistance 61 macrolide antibiotic 61 systemic toxicity 61 Amplimexon 61 renoprotective 61 Azilect ® 61 PRT# 61 rufinamide 61 BENICAR HCT 61 NSAID induced 61 dihydrochloride 61 oral Hycamtin 61 tricyclic antidepressant 61 grade cervical intraepithelial 61 Radical prostatectomy 61 PAOD 61 Darapladib 61 serum creatinine levels 61 VAPRISOL 61 SIRT1 activator 61 Candida infection 61 spironolactone 61 fluvastatin 61 amisulpride 61 cobiprostone 61 APTIVUS r 61 anti angiogenic agents 61 ELACYT 61 thyroid deficiency 61 tolevamer 61 operable breast cancer 61 efalizumab 61 BCG refractory 61 flavopiridol 61 proliferative diabetic retinopathy 61 gastrointestinal stromal tumors GIST 61 Vidaza ® 61 interferon gamma 1b 61 fasting triglycerides 61 acarbose 61 Combination therapy 61 sulfasalazine 61 LTB4 61 upper gastrointestinal bleeding 61 arsenic trioxide 61 glatiramer 61 NAGS deficiency 61 neurologic progression 61 oral vancomycin 61 levosimendan 61 Ranolazine 61 antiproliferative effects 61 darapladib 61 transfusion syndrome 61 IFN alfa 61 spermidine 61 atherogenic dyslipidemia 61 metastatic malignant melanoma 61 canakinumab 61 pimecrolimus 61 pentamidine 61 lowering homocysteine 61 VFEND 61 phosphorus binders 61 vitamin K1 61 Anthracycline 61 peginterferon 61 rimonabant #mg 61 transdermal estrogen 61 contralateral breast 61 CYT# QbG# 61 gallium nitrate 61 triglyceride lowering 61 oesophageal adenocarcinoma 61 serum homocysteine 61 hematologic toxicity 61 palifermin 61 doripenem 61 nitroprusside 61 mitoxantrone 61 elevated IOP 61 SAMe 61 synthetic lethality 61 serous ovarian cancer 61 letrozole Femara 61 antithrombotic 61 premenstrual syndrome PMS 61 treat hyperphosphatemia 61 immune suppressing 61 anterior uveitis 61 pancreatic lung 61 Prostatitis 61 dalteparin 61 bypass grafting 61 teriflunomide 61 bronchial hyperresponsiveness 61 ginkgo biloba extract 61 angiogenesis inhibitor 61 p# activation 61 chronic periodontitis 61 avosentan 61 nab paclitaxel 61 eosinophilic pneumonia 61 fluconazole resistant 61 anthracycline chemotherapy 61 latent tuberculosis TB 61 refractory gout 61 quetiapine Seroquel 61 Aptivus ® 61 PSMA ADC 61 cytostatic 61 immune modulating 61 biologic DMARD 61 HER2 positivity 61 pneumonectomy 61 pimozide 61 metaglidasen 61 NMIBC 61 kallikrein 61 microvascular disease 61 piperacillin tazobactam 61 antimetabolite 61 pleurodesis 61 pramlintide metreleptin combination 61 HSCT 61 variant angina 61 multivariate adjustment 61 Bezielle 61 HNSCC 61 systemic hypotension 61 Soy isoflavones 61 tiuxetan 61 antiinflammatory 61 anthracycline containing 61 cerebral ischemia 61 elevated ALT 61 cephalosporin antibiotics 61 PSADT 61 Egrifta 61 H. pylori infection 61 Vidaza azacitidine 61 cardioprotective effects 61 MEVACOR 61 antiemetic 61 talabostat 61 SGPT 61 pulmonary hypertension PH 61 elevated LDL cholesterol 61 ovarian carcinoma 61 LEXIVA r 61 vorinostat 61 COPAXONE R 61 ischemic cardiomyopathy 61 alkaline phosphatase ALP 61 Temsirolimus 61 LY# [003] 61 receiving XGEVA 61 mucosal inflammation 61 diuretic hydrochlorothiazide 61 pegylated interferon alfa 61 lipid lowering drugs 61 carbohydrate absorption 61 pharmacological therapies 61 HIV HCV coinfected 61 prostanoid 61 gross hematuria 61 gliclazide 61 antibiotic regimens 61 thyrotoxicosis 61 terazosin 61 echocardiographic parameters 61 antiplatelet medications 61 Mg Usa 61 Tacrolimus 61 anticancer activity 61 acute mania 61 intestinal permeability 61 PPARγ 61 A1PI 61 immunomodulation 61 fusion enhancers 61 femoral neck fracture 61 tiotropium bromide 61 paroxetine sertraline 61 HER2 overexpression 61 5-FU/LV 61 hawthorn extract 61 gemcitabine chemotherapy 61 divalproex sodium 61 liver scarring 61 hypervascular tumors 61 ovulatory cycles 61 potentially hepatotoxic 61 Mitoxantrone 61 hydralazine 61 rhThrombin 61 CLA supplementation 61 Vandetanib 61 diabetic peripheral neuropathy DPN 61 NUCYNTA ™ 61 assessing T DM1 61 FVIII inhibitors 61 IMA# 61 platelet clumping 61 Nilotinib 61 enalapril 61 ß blockers 61 liver histology 61 strontium ranelate 61 TRUS biopsy 61 postprandial glycemia 61 antitumor efficacy 61 HuLuc# 61 esophagogastric 61 pre malignant lesions 61 Torisel 61 NPH insulin 61 beta blocker atenolol 61 chlamydial 61 Mylotarg 61 imiquimod 61 FOLFIRI 61 fenretinide 61 pain palliation 61 Paraplatin ® 61 G6PD deficiency 61 cardiac repolarization 61 verteporfin 61 tretinoin 61 urinary oxalate 61 muraglitazar 61 HAART regimen 61 debulking surgery 61 transferrin saturation 61 nephrotoxic 61 urinary excretion 61 AZILECT ® 61 latent tuberculosis infection 61 administered concomitantly 61 HeFH 61 cyclophosphamide methotrexate 61 catheter angiography 61 menadione 61 enzastaurin 61 metastatic RCC 61 paclitaxel Taxol R 61 invasive lobular 61 antithrombotics 61 postoperative mortality 61 endothelial activation 61 Barrett esophagus BE 61 collagen degradation 61 malignant ascites 61 diarrhea predominant irritable 61 AA Amyloidosis 61 ALT elevation 61 erlotinib Tarceva ® 61 HuMax EGFr 61 TAXOTERE ® 61 myeloproliferative diseases 61 DAPT 61 Lofexidine 61 plasma homocysteine 61 revascularizations 61 UDCA 61 BEXXAR Therapeutic Regimen 61 chlamydial infection 61 Subgroup analysis 61 statin medications 61 eflornithine 61 p = NS 61 ciclosporin 61 PHPT 61 plasma kallikrein 61 iron chelators 61 tirofiban 61 PCNSL 61 vandetanib 61 intravenous diuretics